2ϩ entry through store-operated channels (SOCs) in the plasma membrane plays an important role in regulation of vascular smooth muscle contraction, tone, and cell proliferation. The C-type transient receptor potential (TRPC) channels have been proposed as major candidates for SOCs in vascular smooth muscle. Recently, two families of transmembrane proteins, Orai [also known as Ca 2ϩ release-activated Ca 2ϩ channel modulator (CRACM)] and stromal interacting molecule 1 (STIM1), were shown to be essential for the activation of SOCs mainly in nonexcitable cells. Here, using small interfering RNA, we show that Orai1 plays an essential role in activating store-operated Ca 2ϩ entry (SOCE) in primary cultured proliferating human aortic smooth muscle cells (hASMCs), whereas Orai2 and Orai3 do not contribute to SOCE. Knockdown of Orai1 protein expression significantly attenuated SOCE. Moreover, inhibition of Orai1 downregulated expression of Na ϩ /Ca 2ϩ exchanger type 1 (NCX1) and plasma membrane Ca 2ϩ pump isoform 1 (PMCA1). The rate of cytosolic free Ca 2ϩ concentration decay after Ca 2ϩ transients in Ca 2ϩ -free medium was also greatly decreased under these conditions. This reduction of Ca 2ϩ extrusion, presumably via NCX1 and PMCA1, may be a compensation for the reduced SOCE. Immunocytochemical observations indicate that Orai1 and NCX1 are clustered in plasma membrane microdomains. Cell proliferation was attenuated in hASMCs with disrupted Orai1 expression and reduced SOCE. Thus Orai1 appears to be a critical component of SOCE in proliferating vascular smooth muscle cells, and may therefore be a key player during vascular growth and remodeling.
C-type transient receptor potential proteins; sarcoplasmic reticulum Ca 2ϩ stores; proliferation STORE-OPERATED CA 2ϩ ENTRY (SOCE) plays an important role in shaping cytoplasmic Ca 2ϩ signals in a variety of cell types including vascular smooth muscle cells (SMCs) (2, 6, 9, 17, 21, 58) . There is accumulating evidence that Ca 2ϩ entry through store-operated channels (SOCs) in the plasma membrane (PM) may be involved in regulating vascular smooth muscle contraction, tone, and cell proliferation (2, 9, 17, 19, 34, 40, 57) . Despite extensive research, the molecular identity of SOCs remains controversial (3, 7) . Numerous reports indicate that C-type transient receptor potential (TRPC) proteins, mammalian homologs of the Drosophila transient receptor potential (trp) channel, are important components of SOCs in vascular SMCs (3, 7, 12, 33, 50) . In particular, TRPC1, TRPC4, and TRPC5 may form, or be part of, the SOCs activated by sarcoplasmic reticulum (SR) Ca 2ϩ store depletion (7, 42, 62, 63) . In contrast to these SOCs, there is a related class of receptor-operated Ca 2ϩ channels (ROCs), composed of other TRPC proteins, TRPC3/6/7 (23, 35, 45) . These channels are activated by diacylglycerols in a store depletion-independent manner (25, 35) . Nevertheless, both SOCs (TRPC1/4/5) and ROCs (TRPC3/6/7) have important functions in vascular smooth muscle; they participate in hyperplasia, remodeling, and the regulation of arterial blood pressure (5, 8, 13, 16, 32, 60, 65) .
One of the first store depletion-activated channels identified was the Ca 2ϩ release-activated Ca 2ϩ (CRAC) channel in mast cells (27) . Recently, two families of transmembrane proteins, Orai [also known as CRAC channel modulator (CRACM)] and stromal interacting molecule 1 (STIM1), were shown to be essential for the activation of SOCs mainly in nonexcitable cells (15, 28, 51, 59, 64) . The role of Orai1 in SOCE was also confirmed in human airway SMCs (44) and in rat "synthetic" aortic myocytes (47) . Orai1 may form the Ca 2ϩ selectivity filter of the CRAC channel (64) , which may be another type of SOC (42) . A point mutation in the gene encoding Orai1 results in defects in T lymphocyte function and severe immunodeficiency in humans (15) . There are two other potential homologs of Orai1 in the mammalian genome, Orai2 and Orai3 (15) . Orai2 may also constitute or contribute to SOCs (39) but not in all tested cells (22, 24) . The role of Orai3 in SOCE is less clear (11, 24) . Orai3, however, can rescue SOCE when Orai1 is knocked down in HEK-293 cells (39) .
Recently, we demonstrated (9) that expression of each of the three members of the Orai family in homogenates of human aorta is negligible. All Orai proteins are, however, readily detected in cultured, proliferating human aortic smooth muscle cells (hASMCs) (9) . STIM1, the putative Ca 2ϩ sensor in the SR, regulates SOC and CRAC channels (28, 43, 56) . STIM1 and Orai1 may interact with TRPC proteins (28, 41) ; the dynamic assembly of a TRPC1-STIM1-Orai1 ternary complex is involved in SOC activation in human salivary glands (41) . Although the role of Orai proteins has been extensively investigated in T lymphocytes, mast cells, and various heterologous expression systems, there is no evidence to date that Orai proteins play a role in SOCE in human vascular smooth muscle.
Here, using fura-2 imaging, RNA interference, and Western blot analysis, we demonstrate that Orai1 is an essential component of SOCs in human primary cultured proliferating aortic smooth muscle cells (hASMCs). In contrast, Orai2 and Orai3 do not contribute to SOCE. Moreover, Orai1 is functionally associated with Na ϩ /Ca 2ϩ exchanger type 1 (NCX1) and PM Ca 2ϩ pump isoform 1 (PMCA1).
MATERIALS AND METHODS
Primary cultured ASMCs. Primary human aortic myocytes were purchased from Lonza Walkersville (Walkersville, MD). Cells were cultured in smooth muscle basal medium (SmBM) containing 5% fetal bovine serum (FBS) at 37°C in a humidified atmosphere of 5% CO 2. hASMCs from passages 2-4 were used for the experiments. Cells were plated on 25-mm glass coverslips for use in fluorescent microscopy experiments, on coverslips with a lettered grid for counting, or on 100-mm cell dishes for biochemical experiments. The medium was changed on days 3 and 6. Experiments were performed on subconfluent cultures on days 6 -7 The imaging system included a Zeiss Axiovert 100 microscope (Carl Zeiss, Thornwood, NY). The dye-loaded cells were illuminated with a diffraction grating-based system (Polychrome V, TILL Photonics). Fluorescent images were recorded with a CoolSnap HQ2 charge-coupled device (CCD) camera (Photometrics, Tucson, AZ). Image acquisition and analysis were performed with a MetaFluor/ MetaMorph Imaging System (Molecular Devices, Downingtown, PA). [Ca 2ϩ ]cyt was calculated by determining the ratio of fura-2 fluorescence excited at 380 and 360 nm as described previously (9, 19) .
Immunoblot analysis. Membrane proteins were solubilized in sodium dodecyl sulfate (SDS) buffer containing 5% 2-mercaptoethanol and were separated by polyacrylamide gel electrophoresis (SDS-PAGE) as described previously (9) . The following antibodies were used: rabbit polyclonal anti-Orai1 and anti-Orai2 (Allomone Laboratories, Jerusalem, Israel), rabbit polyclonal anti-Orai3 (ProSci, Poway, CA), monoclonal anti-NCX1 (clone R 3F1; Swant, Bellinzona, Switzerland), polyclonal anti-PMCA1 (Affinity Bioreagents, Rockford, IL), rabbit monoclonal anti-TRPC1 (Epitomics, Burlingame, CA), rabbit polyclonal anti-TRPC4 (Allomone Laboratories), and mouse monoclonal anti-TRPC5 (Abnova, Taipei, Taiwan). Gel loading was controlled with monoclonal or polyclonal anti-␤-actin antibodies (Sigma-Aldrich, St. Louis, MO) or monoclonal anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) antibody (Abcam, Cambridge, MA). After being washed, membranes were incubated with anti-rabbit horseradish peroxidase-conjugated IgG for 1 h at room temperature. The immune complexes on the membranes were detected by Enhanced Chemiluminescence-Plus (Amersham Biosciences) and exposure to X-ray film (Eastman Kodak, Rochester, NY). Quantitative analysis of immunoblots was performed with a Kodak DC120 digital camera and 1D Image Analysis Software (Eastman Kodak).
Small interfering RNA knockdown. Primary cultured hASMCs were transfected with the small interfering (si)RNA ON-Target plus Smart pool (20 M) designed against Orai1, Orai2, Orai3 or siCONTRL (Dharmacon, Lafayette, CO). The sequences of the Orai1/siRNA duplexes were as follows: 5Ј-AGACGAUAAAGAUCAGGCCUU-3Ј, 5Ј-CAU-GAGCGCAAACAGGUGCUU-3Ј, 5Ј-CUGUAAGCGGGCAAACUC-CUU-3Ј, and 5Ј-UGCAUGGAGUGCUCGUUGAUU-3Ј. The sequences of the Orai2/siRNA duplexes were 5Ј-UUAGAGGUGACCAGUUCCAUU-3Ј, 5Ј-CGAUAGGCACGUUAAGCUCUU-3Ј, 5Ј-GUCCCGGUAAUC-CAUGCCCUU-3Ј, and 5Ј-AGAGUAGGAUGCCAAGCACUU-3Ј. The sequences of the Orai3/siRNA duplexes were 5Ј-UCUAGUUCCUGCU-UGUAGCUU-3Ј, 5Ј-CAUGAGUGCAAAGAGGUGCUU-3Ј, 5Ј-AAC-CAACCAGGACAACUUCUU-3Ј, and 5Ј-GACUAAGGGAGGUAGC-CACUU-3Ј. Twenty-four hours before treatment, ASMCs were placed in the culture medium (SmBM) without antibiotics and further transfected with siRNA and Lipofectamine 2000 reagent in Opti-MEM (Invitrogen). After 24-h incubation, the medium was aspirated and replaced with SmBM without siRNA for 77 h before Ca 2ϩ measurements or Western blot analysis was performed.
Immunocytochemistry. hASMCs were immunolabeled as described previously (20) . Briefly, cells were fixed in cyclohexylamine-formaldehyde fixative consisting of 0.45% (wt/vol) formaldehyde and (in mM) 75 cyclohexylamine, 75 NaCl, 10 EGTA, 10 MgCl 2, and 10 PIPES. After fixation, the cells were permeabilized in fixative containing 0.5% polyoxyethylene 20 cetyl ether (Brij 58) and were then incubated (4 -17 h) in antibody buffer containing antibodies against Orai1 (Allomone Laboratories) and NCX1 (clone R 3F1, Swant). FITC-labeled donkey anti-mouse IgG or Cy3-conjugated donkey anti-rabbit IgG (Jackson ImmunoResearch, West Grove, PA) was used to visualize the primary antibodies. The fluorescence from the secondary antibody in the absence of primary antibody (positive control) did not exceed 2-3% of the fluorescence in the presence of antiserum.
Materials. SmBM was purchased from Lonza (Walkersville, MD). Jurkat whole cell lysate was obtained from Abcam. Fura-2 AM was obtained from Molecular Probes (Invitrogen Detection Technologies, Eugene, OR). Cyclopiazonic acid (CPA), dimethyl sulfoxide, and nifedipine were purchased from Sigma. All other reagents were analytic grade or the highest purity available.
Statistical analysis. Numerical data presented are means Ϯ SE from n single cells (1 value per cell). Western blot experiments were repeated at least four to six times for each protein. Data from five to seven transfections were obtained for most siRNA protocols as were consistent for all two to four passages. Statistical significance was determined by Student's t-test and ANOVA. Differences were considered to be significant when P Ͻ 0.05.
RESULTS

Orai1 is an essential contributor to SOCE in human primary cultured proliferating aortic cells. Proliferating hASMCs ex-
press all three Orai family members at the protein level. Western blot analysis of Orai1, Orai2, and Orai3 (Fig. 1A, 5A , and 6A) revealed prominent bands close to their predicted molecular masses of 33, 28, and 32.5 kDa, respectively (24) . To determine whether Orai proteins are involved in SOCE in hASMCs, we used siRNA-mediated silencing of Orai(s). Transfection with Orai1/siRNA resulted in 82 Ϯ 4% knockdown of Orai1 protein (Fig. 1, A and B) .
To examine SOCE, Ca 2ϩ stores were depleted in the absence of extracellular Ca 2ϩ with CPA, a specific inhibitor of sarco(endo)plasmic reticulum Ca 2ϩ -ATPase (SERCA). Then, after store depletion, Ca 2ϩ was added back and the rise in [Ca 2ϩ ] cyt due to SOCE was measured (Fig. 1C) . In hASMCs, a large SOCE is activated when SR Ca 2ϩ stores are depleted with 10 M CPA (1,142 Ϯ 71 nM, n ϭ 52; not shown) (9) . Cell transfection with nontargeting siRNA (siControl) (Fig. 1,  C and D 164) (Fig. 1, C and D) (Fig. 1D) . The stored Ca 2ϩ , evaluated by measuring peak amplitudes of CPA-induced Ca 2ϩ transients in Ca 2ϩ -free medium, was also not changed in cells treated with Orai1/siRNA (Fig. 1, C and D) . Transfection with Orai1/ siRNA did not affect expression of Orai2 (Fig. 1, E and F) or Orai3 (Fig. 1, G and H) . Attenuation of the SOC-mediated rise of [Ca 2ϩ ] cyt was not due to a nonspecific effect of Orai1/ siRNA on the expression of TRPC1/4/5 proteins. Indeed, TRPC1 (Fig. 1, I and J) and TRPC4 and TRPC5 (not shown) protein expression was not changed in hASMCs treated with Orai1/siRNA. Both control and siRNA-treated cells retained normal morphology, but hASMC proliferation was markedly inhibited in the Orai1/siRNA-treated group (Fig. 1K) (Fig. 1C, Fig. 2A) . The time course of [Ca 2ϩ ] cyt decline can be represented by a sum of two exponential decays,
where A, B, and Y 0 are constants, t is time, and f and s represent the fast and slow time constants.
Taking logarithms: 1C, Fig. 2, A and B) .
Immunocytochemistry was used to elucidate the relationship between the specific location of Orai1 and NCX1 proteins in the PM (Fig. 3) . High-power images of a portion of an hASMC show that the Orai1 labeling pattern (Fig. 3A, inset) is remarkably similar to the pattern observed with antibodies directed against the NCX1 (Fig. 3B, inset) . Indeed, when Fig. 3Ca (red) is overlaid on Fig. 3Cb (green) , extensive overlap of the labels is observed (Fig. 3Cc) , as indicated by the large amount of yellow in the image. Notably, reactivity was not detected in the PM in the absence of the primary anti-Orai1 (Fig. 3D) (Fig. 1C) , the experiments were repeated at low extracellular Na ϩ concentration ([Na ϩ ] o ). Figure 4A shows that the rate of [Ca 2ϩ ] cyt decay following the initial CPAinduced Ca 2ϩ transient was greatly reduced in Ca 2ϩ -free solution containing 5 mM Na ϩ (conditions that block NCX1-mediated Ca 2ϩ extrusion). Figure 4B shows an example of the analysis of the [Ca 2ϩ ] cyt decay in the gray boxed area in Fig.  4A similar to the analysis shown in Fig. 2B (Fig. 5, A and B) without affecting Orai1 (Fig. 5, E and F) and Orai3 (Fig. 5, G and H) . Moreover, selective inhibition of Orai2 did not affect the SOC-mediated rise in [Ca 2ϩ ] cyt (1,084 Ϯ 77 vs. 1,056 Ϯ 60 nM in cells treated with nontargeting siRNA) (Fig. 5, C and D) . The resting [Ca 2ϩ ] cyt level and the amplitude of CPA-induced Ca 2ϩ transients in Ca 2ϩ -free medium also were not changed significantly under these conditions (Fig. 5D ).
Cell transfection with siRNA targeted to the Orai3 gene resulted in 68 Ϯ 7% knockdown of Orai3 protein expression (Fig. 6, A and B) without affecting expression of Orai1 (Fig. 6 , E and F) or Orai2 (Fig. 6, G and H) . Inhibition of Orai3 expression (Fig. 6, A and B) did not affect SOCE (1,084 Ϯ 77 vs. 1,026 Ϯ 125 nM in cells treated with nontargeting siRNA) ( Fig. 6, C and D) . Resting [Ca 2ϩ ] cyt and stored Ca 2ϩ levels, evaluated by measuring peak amplitudes of CPA-induced Ca 2ϩ transients in Ca 2ϩ -free medium, were also not changed in cells treated with Orai3/siRNA (Fig. 6, C and D) . In contrast to knockdown of Orai1, inhibition of Orai2 or Orai3 did not affect proliferation of hASMCs significantly (data not shown). The results indicate that Orai2 and Orai3 do not play a role in activation of SOCE in proliferating hASMCs.
DISCUSSION
Molecular identification of SOCs is essential for studying the function of SOCE in various types of cells. Over the 20 years since the concept of "capacitative" or store-operated Ca 2ϩ entry was proposed, TRPC channels have been considered the main candidates for SOCs (42) . Some reports, however, indicate that the implication of TRPC channels in SOCE can vary substantially in different types of cells or under different experimental conditions (48) . The recent discovery that Orai proteins are pore-forming subunits of CRAC channels in T lymphocytes and other hematopoietic cells does not, however, indicate that these proteins are involved in activation of SOCE in human vascular SMCs. Here, we provide such evidence. Using siRNAs, we show that Orai1 plays an essential role in activation of SOCE in primary cultured proliferating hASMCs, whereas Orai2 and Orai3 do not contribute to SOCE. Moreover, Orai1 is functionally associated with NCX1 and PMCA1. This conclusion is also supported by immunocytochemical observations showing that Orai1 and NCX1 proteins are localized in the PM in close proximity.
The role of Orai1 and STIM1, as critical components of SOCE, was initially discovered through genomewide RNA interference screens in Drosophila (15, 51, 59 ). The mammalian homolog of Orai1 is located in the PM. This homolog appears to have four transmembrane domains that form the pore of CRAC channels in hematopoietic cells and in a variety of heterologous expression systems (15, 28, 41) . STIM1 is a Ca 2ϩ -binding protein located mainly in the endoplasmic reticulum (ER) membrane with a single transmembrane region (48, 51). The Ca 2ϩ -sensing domain is an EF-hand in the NH 2 terminal that resides in the lumen of the ER. Evidence indicates that depletion of intracellular Ca 2ϩ stores triggers STIM1 to translocate into defined ER-PM "junctional" areas in which coupling to Orai proteins can occur (54) . Coexpression of Orai1 and STIM1 in HEK-293 cells generates Ca 2ϩ releaseactivated Ca 2ϩ current (I CRAC ) and significantly increases SOCE (24, 64) . Expression of Orai1 alone, however, decreases SOCE, whereas expression of STIM1 does not affect SOCE (10). STIM1 associates not only with Orai1 but also with TRPC1 (28, 41) , suggesting that SOCs and CRAC channels are regulated by similar molecular components (4). The majority of functional TRPC channels are heterotetrameric complexes of different TRPC subunits (3, 7) . TRPC1 associates with TRPC4 and TRPC5 to determine the PM expression and function of TRPC-containing channels (4, 18, 26) . When one of the TRPC subunits is suppressed, compensatory upregulation of other subunits can be observed (13) . Recent studies revealed that Orai1 mediates the interaction between STIM1 and TRPC1 and regulates activation of TRPC1-forming Ca 2ϩ channels in human platelets (29) and in HEK-293 cells (10, 38) .
SOCs in vascular SMCs and I CRAC in nonexcitable cells have striking differences in biophysical properties, permeabilities to Ca 2ϩ , and activation mechanisms (3, 21, 37, 53) . This indicates that the molecular composition of SOCs and I CRAC may be different. It has been proposed that I CRAC consist of Orai proteins, whereas SOCs may rather represent heterotetrameric TRPC structures (3). This view is supported by our observation that native arteries readily express TRPC1 and TRPC5 proteins but do not express Orai proteins (9) . Expression of Orai1 and Orai3 mRNA also was not detected in mouse aorta, although very low-level expression of Orai2 mRNA was previously demonstrated (55) . Therefore, SOCE in native arterial myocytes is attributable to the activity of TRPC1 and TRPC5 channels. In cultured proliferating human aortic cells, which abundantly express Orai2, Orai3, and much less Orai1 (9) , the role of these proteins in SOCE can be more significant.
Indeed, the present study demonstrates that Orai1 is involved in SOCE in primary cultured proliferating hASMCs. Cell transfection with Orai1/siRNA reduced by ϳ80% expression of Orai1 protein (Fig. 1, A and B) and SOCE (Fig. 1, C and  D) . Orai2 and Orai3, however, do not contribute to SOCE in -free medium (Fig. 2, A  and B) . The double-exponential fits of the [Ca 2ϩ ] cyt decay data show that f was increased by approximately twofold and s by ϳ50% in cells transfected with Orai1/siRNA. The data are consistent with the observed approximately twofold downregulation of NCX1 and PMCA1 (Fig. 2, C-F) . These are the primary mechanisms of Ca 2ϩ extrusion from the cytosol after cell activation. Ultimately, [Ca 2ϩ ] cyt is determined by the balance between Ca 2ϩ influx and extrusion. In proliferating vascular SMCs, SOCE is the main pathway through which myocytes gain Ca 2ϩ when SR Ca 2ϩ stores are depleted (9, 19) . The contribution of L-type voltage-gated Ca 2ϩ channels, critical in regulating smooth muscle contraction, is markedly decreased in dedifferentiated, proliferating aortic myocytes (49) . Therefore, downregulation of NCX1 and PMCA1 and the reduction of Ca 2ϩ extrusion in hASMCs with inhibited Orai1 and SOCE may compensate for the reduced SOCE in order to maintain sufficient Ca 2ϩ levels in the cytosol and within the SR. It was previously reported that NCX1 operating in the Ca 2ϩ entry mode may contribute to SOCE in cultured human pulmonary artery and rat aorta myocytes and in T3-9 cells (46, 52, 67) . For example, SOCE in T3-9 cells was substantially suppressed by 5 M KB-R7943, an inhibitor of NCX (52) . KB-R7943 is, however, nonselective, e.g., it also blocks currents through TRPC3/5/6 (IC 50 ϭ 0.46 -1.38 M) (31) . When experiments were performed at low (5 mM) [Na ϩ ] o , SOCE was much less diminished (52) . Our data indicate that NCX1 is involved in [Na ϩ ] o -dependent Ca 2ϩ extrusion from the cytosol (Fig. 4, A and B) but apparently does not contribute to the SOCE in cultured hASMCs. These differences may be explained by relative differences in the contribution of NCX to SOCE in different cell types.
The functional interaction of NCX1 and Orai1 raises the possibility of their clustering in the PM-junctional SR regions. Notably, that NCX1 (30) and TRPC channels (20) are confined to the PM microdomains that overlie the closely apposed junctional SR where STIM1 accumulates after store depletion (61) . Moreover, coimmunoprecipitation experiments provide evidence for association of NCX1 with TRPC3 in protein complexes in HEK-293 cells (52) . In the present study immunocytochemistry with anti-Orai1 and anti-NCX1 antibodies revealed the close proximity of Orai1 and NCX1 proteins in the PM (Fig. 3) . These findings indicate that PM microdomains that include Orai1-containing channels and NCX1 function as integrated units that help to regulate Ca 2ϩ signals in vascular SMCs.
Previously, we demonstrated (19, 21) that proliferation of human pulmonary artery SMCs is associated with enhanced SOCE. The present study shows that SOCE also plays an essential role in proliferation of human aortic SMCs. Inhibition of SOCE in cells with disrupted Orai1 protein expression significantly attenuated hASMC proliferation (Fig. 1K) . Knockdown of Orai2 or Orai3, however, did not affect SOCE and hASMC proliferation. The data confirm a previous report demonstrating an essential role of Orai1 but not Orai2 or Orai3 in proliferation and migration of rat aortic SMCs (47) . Augmented expression of Orai proteins in proliferating aortic myocytes (9) might also implicate Orai in arterial phenotype modulation.
In conclusion, one of the key results of this study is that knockdown of Orai1 dramatically reduces SOCE in primary cultured proliferating hASMCs. This establishes the role of Orai1 as a critical component of arterial SOCE, which is essential for cell proliferation. The implication is that Orai1 is required for activation of SOCE not only in nonexcitable cells, such as T lymphocytes and other hematopoietic cells, but also in proliferating human vascular SMCs. Moreover, Orai1 and NCX1 proteins are localized in the PM in close proximity. Such specialized distribution of Orai1 and NCX1 facilitates their functional interaction. The data suggest that Orai1 may play a critical role in an altered Ca 2ϩ handling associated with cell proliferation, for example, during vascular growth and remodeling.
